Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective Adaptive Response Placebo-controlled Double-blind Study Comparing Effects of Rosuvastatin Versus Placebo

NCT01881971 is registered in ClinicalTrials.gov with Alison Morris as lead sponsor.

NCT NCT01881971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01881971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective Adaptive Response Placebo-controlled Double-blind Study Comparing Effects of Rosuvastatin Versus Placebo
Lead sponsor
Alison Morris
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2013
Completion date
January 31, 2016
Enrollment
23 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv seropositivity